Description
In November 2024, Mindray unveiled Resona A20 at EUROSON 2024 in Naples, Italy.
By revealing the unseen, we empower you to embark on a transformative journey of discovery and understanding, enabling a deeper comprehension of human body and the world around us.
Driven by this mission, Mindray is about to release the premium ultrasound system – Resona A20. Powered by the Acoustic Intelligence Technology platform, it has pushed ultrasound imaging performance to a new level, helping clinical experts to achieve accurate diagnosis and academic exploration. Together, we can explore new horizons and push the boundaries of medical knowledge.
End Users:
- Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology (华中科技大学同济医学院附属同济医院, Wuhan City, China, November 2024)
G-MedTech Reviews –
“The Resona A20 was developed for multi-parametric ultrasound. I believe this will change the approach to patient care. In the past, with ultrasound, we could only determine whether the structure was normal or not. Now, we can understand if there is an underlying disease.”
— Dr. Alfredo Goddi, Managing Director, SME – Diagnostica per Immagini Medical Center, Italy
G-MedTech Reviews –
“This is where Resona A20 comes in. Today, using the A20 technology with new super-resolution CEUS we can find liver tumors of less than five millimeters. By detecting tumors with less than 10 millimeters we can use this technology during treatment, e.g. for ablation therapies. This will probably change the way we look at surgery in the future.”
— Prof. Ernst Michael Jung, Head of the Ultrasound Center at University Hospital Regensburg, Germany